Home-Administered Trial of Direct Current Stimulation (HAT-DCS)
Primary Purpose
Major Depression
Status
Completed
Phase
Not Applicable
Locations
Australia
Study Type
Interventional
Intervention
Soterix tDCS machine
Sponsored by

About this trial
This is an interventional treatment trial for Major Depression
Eligibility Criteria
Inclusion Criteria:
- Subject meets criteria for a DSM-IV Major Depressive Episode, lasting more than 4 weeks
- Total MADRS score ≥ 20
Exclusion Criteria:
- Diagnosis of any DSM-IV psychotic disorder
- History of drug or alcohol abuse or dependence in the preceding 3 months
- High suicide risk
- Clinically defined neurological disorder or insult
- Metal in the cranium or skull defects
- Skin lesions on the scalp (e.g. cuts, abrasions, rashes) at the proposed electrode sites
- Pregnancy
Sites / Locations
- Black Dog Institute
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Active tDCS
Arm Description
Soterix tDCS machine is used to administer active stimulation
Outcomes
Primary Outcome Measures
Montgomery Asberg Depression Rating Scale for Depression (MADRS)
Secondary Outcome Measures
Full Information
NCT ID
NCT02894736
First Posted
September 5, 2016
Last Updated
August 1, 2018
Sponsor
The University of New South Wales
1. Study Identification
Unique Protocol Identification Number
NCT02894736
Brief Title
Home-Administered Trial of Direct Current Stimulation
Acronym
HAT-DCS
Official Title
Home-administered Transcranial Direct Current Stimulation (tDCS) Treatment for Depression
Study Type
Interventional
2. Study Status
Record Verification Date
August 2018
Overall Recruitment Status
Completed
Study Start Date
March 2016 (undefined)
Primary Completion Date
March 2018 (Actual)
Study Completion Date
July 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The University of New South Wales
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Transcranial Direct Current Stimulation (tDCS) is a novel non-invasive brain stimulation treatment that is effective with no significant side effects. It can potentially be self-administered by patients in their own homes with remote monitoring, substantially reducing treatment costs and increasing accessibility, including to remote areas. This study will evaluate the feasibility and efficacy of home-administered tDCS treatment for depression.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Major Depression
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
34 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Active tDCS
Arm Type
Experimental
Arm Description
Soterix tDCS machine is used to administer active stimulation
Intervention Type
Device
Intervention Name(s)
Soterix tDCS machine
Intervention Description
Soterix tDCS machine - miniCT supervised neuromodulation system
Primary Outcome Measure Information:
Title
Montgomery Asberg Depression Rating Scale for Depression (MADRS)
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Subject meets criteria for a DSM-IV Major Depressive Episode, lasting more than 4 weeks
Total MADRS score ≥ 20
Exclusion Criteria:
Diagnosis of any DSM-IV psychotic disorder
History of drug or alcohol abuse or dependence in the preceding 3 months
High suicide risk
Clinically defined neurological disorder or insult
Metal in the cranium or skull defects
Skin lesions on the scalp (e.g. cuts, abrasions, rashes) at the proposed electrode sites
Pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Angelo Alonzo, BSc(Hons)/BA, PhD
Organizational Affiliation
University of New South Wales / Black Dog Institute
Official's Role
Principal Investigator
Facility Information:
Facility Name
Black Dog Institute
City
Randwick, Sydney
State/Province
New South Wales
ZIP/Postal Code
2031
Country
Australia
12. IPD Sharing Statement
Learn more about this trial
Home-Administered Trial of Direct Current Stimulation
We'll reach out to this number within 24 hrs